US Patent Issued to Takeda Pharmaceutical on Oct. 21 for "Heterocyclic compound" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,377, issued on Oct. 21, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Heterocyclic compound" was invented by Yoshiteru Ito (Kanagawa, Japan), Yuhei Miyanohana (Kanagawa, Japan), Yuichi Kajita (Kanagawa, Japan), Yasutaka Hoashi (Kanagawa, Japan), Yasushi Hattori (Kanagawa, Japan), Tatsuki Koike (Kanagawa, Japan), Norihito Tokunaga (Kanagawa, Japan), Eiji Kimura (Kanagawa, Japan), Alexander Martin Pawliczek (Kanagawa, Japan), Marilena Pira (Kanagawa, Japan) and Javier Miguelez-Ramos (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a heterocyclic compound having an orexin type 2 receptor a...